Aldeyra Therapeutics Inc. (ALDX)

NASDAQ: ALDX · Real-Time Price · USD

2.88

0.17 (6.27%)

At close: May 02, 2025, 3:05 PM

Aldeyra Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	54.53M	142.82M	144.42M	229.79M	77.86M	44.43M	47.36M	20.02M	12.02M
Short-Term Investments	46.62M	n/a	29.88M	n/a	n/a	28.94M	46.24M	22.92M	12.9M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	267.26K	n/a	n/a	-96.13K	-63.74K	-54.91K	86.64K	165.93K	n/a
Receivables	n/a	n/a	3.24M	125M	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	-3.24M	-125M	-20.21M	-28M	n/a	n/a	n/a
Other Current Assets	301.15K	4.99M	6.72M	2.5M	4.79M	1.4M	n/a	n/a	218.68K
Total Current Assets	101.86M	147.81M	181.02M	232.75M	83.06M	75.17M	94.77M	43.97M	25.13M
Property-Plant & Equipment	266.95K	516.58K	268.54K	384.35K	293.24K	349.46K	235.22K	43.26K	56.35K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	534.22K	516.58K	268.54K	384.35K	293.24K	349.46K	321.87K	209.19K	56.35K
Total Assets	104.61M	148.33M	181.29M	233.14M	83.35M	75.52M	95.09M	44.17M	25.19M
Account Payables	180.45K	1.34M	133.63K	1.02M	381.64K	808.3K	3.05M	1M	275.44K
Deferred Revenue	6M	400.23K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	31.37K	15.39M	1.16M	n/a	3.66M	n/a	n/a	116.32K	77.55K
Other Current Liabilities	12.12M	2.85M	9.99M	9.01M	6.81M	10.38M	4.25M	1.45M	962.8K
Total Current Liabilities	18.6M	22.26M	15.36M	11.77M	12.41M	12.91M	8.47M	3.35M	2.3M
Long-Term Debt	n/a	271.63K	14.92M	15,628.9B	11.43M	14.53M	n/a	1.22M	1.24M
Other Long-Term Liabilities	n/a	-271.63K	n/a	-15,628.9B	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	15M	6.27M	14.92M	15.63M	11.43M	14.53M	n/a	1.22M	1.24M
Total Liabilities	33.6M	28.53M	30.28M	27.4M	23.84M	27.44M	8.47M	4.57M	3.54M
Total Debt	15.3M	15.66M	16.08M	15.86M	15.33M	14.75M	n/a	1.34M	1.32M
Common Stock	59.65B	59.2K	58.56K	58.08K	38.67K	28.66K	26.24K	19.14K	12.58K
Retained Earnings	-450.11M	-394.26M	-356.72M	-294.69M	-236.92M	-199.36M	-138.54M	-99.64M	-77.3M
Comprehensive Income	37.44B	n/a	-103.94K	n/a	n/a	5.87K	-9.22K	-17.83K	129.00
Shareholders Equity	71M	119.8M	151.01M	205.74M	59.51M	48.08M	86.62M	39.6M	21.65M
Total Investments	46.62M	n/a	29.88M	n/a	n/a	28.94M	46.24M	22.92M	12.9M